1)村島温子,他 : 膠原病・リウマチ疾患と妊娠・授乳ハンドブック.pp14-16,南山堂,2019
2)Clowse ME, et al : The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52 : 514-521, 2005
3)荒田尚子 : プレコンセプションケアと産後フォローアップ.医学のあゆみ256 : 199-205, 2016
4)Doran MF, et al : Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46 : 625-631, 2002
5)Del Junco DJ, et al : The relationship between rheumatoid arthritis and reproductive function. Br J Rheumatol 28(Suppl 1) : 33 ; discussion 42-45, 1989
6)Brouwer J, et al : Fertility in women with rheumatoid arthritis : influence of disease activity and medication. Ann Rheum Dis 74 : 1836-1841, 2015
7)Weber-Schoendorfer C, et al : Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy : a prospective multicenter cohort study. Arthritis Rheumatol 66 : 1101-1110, 2014
8)Clowse ME, et al : A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199 : 127.e1-127.e6, 2008
9)Mortiz MJ : National Transplantation Pregnancy Registry 2015 Annual Report. 2015
10)Clowse ME, et al : Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54 : 3640-3647, 2006
11)Buyon JP, et al : Autoimmune-associated congenital heart block : demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31 : 1658-1666. 1998
12)「自己抗体陽性女性の妊娠管理指針の作成及び申請時ループスの発症リスクの軽減に関する研究」研究班 : 抗SS-A抗体陽性女性の妊娠に関する診療の手引き.2013
13)Izmirly PM, et al : Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 124 : 1927-1935, 2011
14)Ziakas PD,et al : Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss : a systematic review and meta-analysis. Obstet Gynecol 115 : 1256-1262, 2010
15)Sammaritano LR, et al : Arthritis Rheumatol 72 : 529-556, 2020
16)Andreoli L, et al : EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76 : 476-485, 2017